Lectures and seminars 2026 CDMRP Funding Opportunities Seminar

Congressionally Directed Medical Research Programs (CDMRP) Announces $1.27 Billion, 34 Research Programs for Fiscal Year 2026. Dollars for the CDMRP are not considered part of the DoD's core mission, and are therefore not included in the DoD's requested budget. Rather, the dollars to fund CDMRP are added every year during the budget approval cycle by members of the House or Senate, in response to requests by consumer advocates and disease survivors, hence the “congressionally directed” part of the program name.

The fiscal year 2026 appropriated research programs include:

Alcohol and Substance Use Disorders, Alzheimer’s, Amyotrophic Lateral Sclerosis, Arthritis, Autism, Bone Marrow Failure Disease, Breast Cancer, Combat Readiness Medical, Duchenne Muscular Dystrophy , Epilepsy, Hearing Restoration, Joint Warfighter Medical, Kidney Cancer, Lung Cancer, Lupus , Melanoma, Military Burn, Multiple Sclerosis, Neurofibromatosis, Orthopaedic, Ovarian Cancer , Pancreatic Cancer, Parkinson’s, Peer Reviewed Cancer (20 topics), Peer Reviewed Medical (52 topics), Prostate Cancer , Rare Cancers, Reconstructive Transplant, Spinal Cord Injury, Tick-Borne Disease, Toxic Exposures, Traumatic Brain Injury and Psychological Health, Tuberous Sclerosis Complex, and Vision.

In this seminar, selected funding opportunities with announced deadlines will be presented. Pre-announcement topics are currently available here: Press Releases, Congressionally Directed Medical Research Program. Keeping apprised of when pre-announcements are posted can be helpful and give you a head start in planning your application.

Registration & Contact: Please send your registration to this email address at grantsoffice@ki.se no later than April 10, 2026. The link to the webinar will be sent out after the registration has been completed.